Logo Image
NP/PA Connect
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference ListingNP/PA Conferences
Events
NP/PA EventsCase-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
Awareness SpotlightInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Watch
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Anti-Aging
  • Artificial Intelligence
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hair & Scalp
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Spotlight -
NP/PA Connect|
Acne|
Atopic Dermatitis|
Chronic Hand Eczema|
Chronic Spontaneous Urticaria|
Drug Watch|
Hidradenitis Suppurativa|
Psoriasis|
Skin Cancer|
Vitiligo
Advertisement

Prurigo Nodularis

Latest News

February 14th 2024
FDA Accepts Galderma’s BLA for Nemolizumab for the Treatment of Prurigo Nodularis and Atopic Dermatitis
By Kaitlyn Bader, Senior Editor

The FDA has also granted nemolizumab Priority Review for prurigo nodularis.

January 9th 2024

Cryosim-1 Safe, Effective in Patients With Prurigo Nodularis

By Emma Andrus, Associate Editor
Advertisement

Latest Videos

New Systemic Treatments for Prurigo Nodularis
New Systemic Treatments for Prurigo Nodularis
Talking to Patients About Itch Management
Talking to Patients About Itch Management
Challenges in Diagnosing Prurigo Nodularis and Distinguishing From Other Pruritic Conditions
Challenges in Diagnosing Prurigo Nodularis and Distinguishing From Other Pruritic Conditions
Prurigo Nodularis Burden of Disease
Prurigo Nodularis Burden of Disease

CME Content

View More
Rethinking Dermatologic Care – Optimizing Dermatologic Outcomes With High-Efficacy Treatments and Proactive Management | Hollywood, FL
In-Person + Virtual Event

Rethinking Dermatologic Care – Optimizing Dermatologic Outcomes With High-Efficacy Treatments and Proactive Management | Hollywood, FL

November 15, 2026

View more
Publication Review: Defining On-Treatment Remission in Plaque Psoriasis
Video

Publication Review: Defining On-Treatment Remission in Plaque Psoriasis

April W. Armstrong, MD, MPH; Tina Bhutani-Jacques MD

View more

Advertisement

More News

  • Prev
  • 1
  • 2
  • 3
  • Prev
Advertisement
Advertisement

Trending on Dermatology Times

1

Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis

2

Dermatology Times Monthly FDA and Pipeline Review: October 2026

3

Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients

4

Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year

5

Updated HS Guidelines Emphasize Biologics and Early Intervention

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us